Tirzepatide demonstrated approximately 5-fold lower affinity at the GLP-1 receptor compared to native GLP-1, and 20-fold lower potency in cellular signaling compared to semaglutide
Research progress Support The animal experiments have achieved remarkable results: In the obese mouse model, after daily subcutaneous injection of AOD 9604 (250 g/kg) for 8 weeks, the body weight of the mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue significantly decreased, confirming its effectiveness in fat reduction
INITIAL APPOINTMENT WITH DR
CHP1 regulates compartmentalized glycerolipid synthesis by activating GPAT4
Any interpretation beyond laboratory research is speculative
With over 20 years of experience, she provides both non-surgical and surgical options tailored to your individual needs